US Stock MarketDetailed Quotes

MAIA MAIA Biotechnology

Watchlist
  • 2.150
  • -0.080-3.59%
Close Nov 21 16:00 ET
  • 2.190
  • +0.040+1.86%
Post 20:01 ET
54.46MMarket Cap-1604P/E (TTM)

About MAIA Biotechnology Company

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Company Profile

SymbolMAIA
Company NameMAIA Biotechnology
Listing DateJul 28, 2022
Issue Price5.00
Founded2018
CEODr. Vlad Vitoc, M.B.A.
MarketAMEX
Employees13
Fiscal Year Ends12-31
Address444 West Lake Street,Suite 1700
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60606
Phone1-312-416-8592

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vlad Vitoc, M.B.A.
  • Chairman of the Board, President and Chief Executive Officer
  • 1.43M
  • Dr. Sergei M. Gryaznov, PhD
  • Chief Scientific Officer
  • 894.75K
  • Jeffrey Himmelreich, M.B.A.
  • Head of Finance and Principal Financial and Accounting Officer
  • 77.66K
  • Jean-Manasse Theagene
  • Independent Director
  • 47.50K
  • Dr. Stan V. Smith, PhD
  • Lead Independent Director
  • 75.00K
  • Ngar Yee Louie
  • Independent Director
  • 90.00K
  • Steven M. Chaouki
  • Independent Director
  • 60.00K
  • Ramiro Guerrero, J.D.,L.L.M.
  • Independent Director
  • 60.00K
  • Cristian Luput
  • Independent Director
  • 60.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data